Autonomic Dysreflexia
📧 Sign up to get email alerts when something new happens for Autonomic Dysreflexia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Treatment of Post-SCI Hypotension [Phase 2, Phase 3]
The document reports completion of Phase 2 and Phase 3 clinical trials investigating treatment for post-spinal cord injury hypotension. Resu…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury [Phase 2]
Phase 2 clinical trial evaluating whether normalizing blood pressure improves cerebral blood flow in hypotensive individuals with spinal cor…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI [Phase 4]
Phase 4 clinical trial update investigating Botox for neurogenic detrusor overactivity and prevention of autonomic dysreflexia after spinal …
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI) [Phase 2]
Phase 2 clinical trial assessing fesoterodine for amelioration of autonomic dysreflexia after spinal cord injury has been completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study [NA]
A completed clinical trial evaluating prazosin for autonomic dysreflexia in individuals with spinal cord injury.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.